115 related articles for article (PubMed ID: 8708538)
1. Parathyroid hormone induces superoxide anion burst in the osteoclast: evidence for the direct instantaneous activation of the osteoclast by the hormone.
Datta HK; Rathod H; Manning P; Turnbull Y; McNeil CJ
J Endocrinol; 1996 May; 149(2):269-75. PubMed ID: 8708538
[TBL] [Abstract][Full Text] [Related]
2. cAMP-dependent inhibition is dominant in regulating superoxide production in the bone-resorbing osteoclasts.
Berger CE; Horrocks BR; Datta HK
J Endocrinol; 1998 Sep; 158(3):311-8. PubMed ID: 9846160
[TBL] [Abstract][Full Text] [Related]
3. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
4. Are osteoblastic cells required for the control of osteoclast activity by parathyroid hormone?
Jilka RL
Bone Miner; 1986 Sep; 1(4):261-6. PubMed ID: 2849485
[TBL] [Abstract][Full Text] [Related]
5. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
Yu X; Schøller J; Foged NT
Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
[TBL] [Abstract][Full Text] [Related]
6. Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway.
Kaji H; Sugimoto T; Kanatani M; Nasu M; Chihara K
Endocrinology; 1996 Jun; 137(6):2217-24. PubMed ID: 8641168
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro.
Saleh H; Eeles D; Hodge JM; Nicholson GC; Gu R; Pompolo S; Gillespie MT; Quinn JM
Endocrinology; 2011 May; 152(5):1911-22. PubMed ID: 21363931
[TBL] [Abstract][Full Text] [Related]
8. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
[TBL] [Abstract][Full Text] [Related]
9. Lycopene I--effect on osteoclasts: lycopene inhibits basal and parathyroid hormone-stimulated osteoclast formation and mineral resorption mediated by reactive oxygen species in rat bone marrow cultures.
Rao LG; Krishnadev N; Banasikowska K; Rao AV
J Med Food; 2003; 6(2):69-78. PubMed ID: 12935316
[TBL] [Abstract][Full Text] [Related]
10. Direct non-genomic effect of steroid hormones on superoxide anion generation in the bone resorbing osteoclasts.
Berger CE; Horrocks BR; Datta HK
Mol Cell Endocrinol; 1999 Mar; 149(1-2):53-9. PubMed ID: 10375017
[TBL] [Abstract][Full Text] [Related]
11. The chemokine Cxcl1 is a novel target gene of parathyroid hormone (PTH)/PTH-related protein in committed osteoblasts.
Onan D; Allan EH; Quinn JM; Gooi JH; Pompolo S; Sims NA; Gillespie MT; Martin TJ
Endocrinology; 2009 May; 150(5):2244-53. PubMed ID: 19147675
[TBL] [Abstract][Full Text] [Related]
12. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
[TBL] [Abstract][Full Text] [Related]
13. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
14. Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.
Greenfield EM; Shaw SM; Gornik SA; Banks MA
J Clin Invest; 1995 Sep; 96(3):1238-44. PubMed ID: 7657797
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
Lee SK; Lorenzo JA
Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
[TBL] [Abstract][Full Text] [Related]
16. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation.
Kano J; Sugimoto T; Kanatani M; Kuroki Y; Tsukamoto T; Fukase M; Chihara K
J Cell Physiol; 1994 Nov; 161(2):358-66. PubMed ID: 7962120
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone stimulates osteoclast-like cell formation by directly acting on hemopoietic blast cells and enhances osteoclast-like cell formation stimulated by parathyroid hormone and prostaglandin E2.
Kaji H; Sugimoto T; Kanatani M; Nishiyama K; Chihara K
J Bone Miner Res; 1997 May; 12(5):734-41. PubMed ID: 9144339
[TBL] [Abstract][Full Text] [Related]
18. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
19. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
20. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo.
Uy HL; Guise TA; De La Mata J; Taylor SD; Story BM; Dallas MR; Boyce BF; Mundy GR; Roodman GD
Endocrinology; 1995 Aug; 136(8):3207-12. PubMed ID: 7628353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
